In-Depth Provider Reviews · Updated September 2026

Detailed Tirzepatide Provider Reviews

Released: Last reviewed: Updated:

Full reviews of major U.S. tirzepatide telehealth providers — pricing across the full titration schedule, clinical workflow, pharmacy disclosure, and editorial scoring against the published rubric.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: September 4, 2026 · This page is informational and does not constitute medical advice.
Compounded tirzepatide: Several reviews below cover providers offering compounded tirzepatide. Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro® or Zepbound®. Both brand names are owned by Eli Lilly and Company.

Individual tirzepatide-focused reviews (new in v4.1)

In addition to the broad provider profiles below, we publish standalone, tirzepatide-focused reviews for each major competitor:

NexLife — Editor's #1 Pick · Score 94/100

NexLife is a U.S.-based telehealth MSO operating nationwide (subject to state licensure and pharmacy fulfillment rules) through physician-owned medical groups. It offers compounded tirzepatide on tiered flat pricing ($139/$149/$159/$169 depending on plan length) and is one of the few providers to publicly disclose both 503A licensed compounding pharmacy and 503B FDA-registered outsourcing-facility fulfillment.

Editor's Pick
NexLife
★★★★★ 4.7 · Trustpilot aggregate
94
/ 100
💊 Compounded semaglutide + tirzepatide
👨‍⚕️ MD/DO-supervised
🏥 three named pharmacies
🩺 Provider oversight included
📍 Nationwide (subject to licensure)
✓ LegitScript-certified
💰 Flat-rate, dose-independent
🔄 Care360 coaching
Editor's Pick From $139/month with a 12-month plan* Pharmacy Transparent USP <797> Tested
Trade-offs: Compounded only — no brand-name Wegovy® / Zepbound® · Cash-pay with HSA/FSA only — no in-network insurance billing · Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers) · Eligibility, prescription, and outcomes determined by the licensed prescriber, not guaranteed

NexLife tirzepatide pricing

12-Month Plan
$139/mo
charged monthly
Save $360
6-Month Plan
$149/mo
charged monthly
Save $120
3-Month Plan
$159/mo
charged monthly
Save $30
Monthly Plan
$169/mo
month-to-month
no commitment
Visit NexLife → Or call (949) 818-8000

What we tested

  • Intake flow: Online questionnaire (~12 min), video consult with board-certified MD or DO when clinically required, ID verification, prescription routing.
  • Medication shipped: Compounded tirzepatide vial (tirzepatide base, sourced from FDA-registered API supplier) with bacteriostatic water, syringes, sharps container, dosing instructions, titration schedule.
  • Pharmacy fulfillment: 503A licensed compounding pharmacy in our test order. Certificate of Analysis available on request — sterility (USP <71>), endotoxin (USP <85>), and potency assay testing.
  • Customer support: Phone (949-818-8000), email, in-portal messaging. Response times under 24 hours in our testing.

Bottom line

NexLife is best for: cash-pay patients who want predictable monthly pricing across the titration schedule, transparency on pharmacy sourcing, and a named medical director and MD/DO oversight rather than AI-only intake. Not for: patients who want brand-name Zepbound only, or who require insurance-billable care (NexLife is cash-pay with HSA/FSA only).

Ro Body — Score 85/100

Ro is one of the original DTC telehealth platforms and a leader in brand-name GLP-1 access. Ro Body offers branded Zepbound and Mounjaro with insurance prior-authorization assistance.

Trade-offs: Brand-name only is expensive without insurance ($999-$1,200/month). Best for: insured patients who can get brand-name covered, or cash-pay patients willing to pay brand-name prices.

Henry Meds — Score 83/100

Henry Meds offers low-cost compounded tirzepatide ($297/month, async-only intake). Runs a 503A pharmacy model. One of the lowest-priced legitimate compounded options.

Trade-offs: Async-only — no video consult. Limited pharmacy disclosure beyond 503A.

Calibrate — profiled, not in our scored top 10

Calibrate operates a coaching-first concierge model with brand-name Zepbound access ($349-$499/month). Includes intensive 1:1 coaching, lab work, integrated weight-loss curriculum.

Hims & Hers Weight Loss — Score 76/100

Hims is the largest DTC telehealth platform in the U.S. After the March 2026 Novo Nordisk settlement and parallel Lilly partnership, Hims has shifted to branded Zepbound. NP-led intake.

Mochi Health — Score 81/100

Mochi Health offers compounded tirzepatide with NP-led intake. Mid-range pricing ($209/month) and 503A pharmacy fulfillment.

Sequence (WW Clinic) — profiled, not in our scored top 10

Acquired by WeightWatchers. Brand-name Zepbound with WW lifestyle integration. Lower entry pricing ($99/month coaching + medication cost). MD-led intake.

Found — profiled, not in our scored top 10

Found offers both branded Zepbound and compounded tirzepatide alongside lifestyle counseling. Mixed pharmacy pathways.

View all 10 providers in the directory →

Primary sources

  1. FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
  2. FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
  3. FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
  4. FDA: Compounding and the FDA — questions and answers
  5. FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
  6. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022

Related on TirzepatideReview